Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$23.1B
98M shares
52-week range
$195.14 – $269.44
51% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NYSE
CS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
www.steris.comNo one on the platform currently holds STE.
No tracked institution reports a position in STE as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-09-04 | $0.6900 | 2026-09-25 |
| 2026-06-08 | $0.6300 | 2026-06-26 |
| 2026-02-17 | $0.6300 | 2026-03-19 |
| 2025-11-18 | $0.6300 | 2025-12-18 |
| 2025-09-04 | $0.6300 | 2025-09-26 |
| 2025-06-10 | $0.5700 | 2025-06-26 |
| 2025-02-20 | $0.5700 | 2025-03-21 |
| 2024-11-19 | $0.5700 | 2024-12-19 |
| 2024-09-05 | $0.5700 | 2024-09-20 |
| 2024-06-12 | $0.5200 | 2024-06-26 |
No one on the platform has traded STE yet.
| 2024-02-22 | $0.5200 | 2024-03-22 |
| 2023-11-20 | $0.5200 | 2023-12-21 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$TOMZ The steramist is about to MTGA ! Buy like crazy. $YUM $STE We need safe lettuce and weed bitches.
View on StockTwits ↗STERIS plc $STE (8h) Bullish Flow: Institutional accumulators are quietly loading shares as $STE builds out its newly authorized $1B share repurchase program and expands its dividend for the 21st consecutive year. absorbing supply right at the lower boundary of a multi-month ascending channel. 🐂 💧 Bull Key Level: $230.00 (Bull confirmation to break local horizontal resistance and accelerate toward upper channel boundary) 🐂 🔥 Bear Key Level: $213.00 (Key structural support floor and ascending trendline anchor to defend) 🐻 ⚠️ Targets: $245.00 / $260.00 💰 🍺 Why: The 8-hour chart displays a textbook ascending pitchfork channel with price bouncing cleanly off lower trendline support. With $982.9M in annual free cash flow providing exceptional balance sheet flexibility and double-digit adjusted EPS growth ($10.17 FY26), holding above $213 keeps the macro bull trend firmly intact. #ste | #stocktrading | #optionsflow | #technicalanalysis | #hovdid
View on StockTwits ↗$STE Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $2.05 up 13.89% YoY • Reported revenue of $1.49B up 7.30% YoY • STERIS reiterates its fiscal 2027 outlook, anticipating as reported revenue growth of 7-8%, constant currency organic revenue growth of 6-7%, and adjusted earnings per diluted share of $11.10 to $11.30.
View on StockTwits ↗$TOMZ Stacked a ton of this bad boy. Malto Bene to 6 log kill and no equipment kill. Will be $5/sp in 6 months. $STE $TSLA
View on StockTwits ↗$TOMZ Buy like crazy now from the clowns that bought high. They never learn. Maybe they graduated from the LEARING center? $TSLA $STE Its all about the patents according to Rick James bitch.
View on StockTwits ↗$TOMZ This is buy time. My cost basis is $0.37 . Got all my cheap shares from people that bought high and sold low. I like to buy low and sell high. This stock has made me millions. $ECL $STE $TSLA
View on StockTwits ↗$STE Current Stock Price: $200.37 Contracts to trade: $210.0 STE Jul 17 2026 Call Entry: $0.90 Exit: $1.22 ROI: 36% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$STE Really good write-up that perfectly summarizes STE's present situation. So if you want to bring your STE knowledge up to date or just discover STE, this is required reading. https://everyticker.com/quote/STE/analysis/steris-margin-expansion-meets-capital-allocation-excellence-in-infection-prevention-nyse-ste
View on StockTwits ↗$TOMZ will eclipse the dollar price today. $STE $ECL Twelve million annual will be in rear view mirror next year. Europe,Africa,Canada all moving to this new technology. BENE !
View on StockTwits ↗$STE - STERIS plc (Ireland) - 10K - Updated Risk Factors STE flags higher exposure to shifting trade rules and USMCA’s 2026 review, new Medicaid and tax uncertainty from the 2025 OBBBA, potential double taxation and GloBE impacts given its Irish parent, expanding ESG and EU/US sustainability reporting burdens, EO-sterilization litigation and settlements, execution risk in smart manufacturing and AI adoption, and greater risk that acquisitions, investments, and realignment initiatives may not deliver expected returns. #HealthcareEquipment #TradePolicyRisk #TaxUncertainty #ESGReporting #AIAdoption 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2026-05-29
View on StockTwits ↗$TOMZ Spraying work areas set up to protect HC workers in Ebola zone. $STE $ECL Next thing you know,will be trading over a buck? Wonder if BSL3-4 in USA use Steramist? Buy.
View on StockTwits ↗$TOMZ Insiders know more about the merger than outsiders. HEHEHE. $STE $ECL Only Steramist can do what it can do. Buy.Buy.Buy again.
View on StockTwits ↗$TOMZ Spray the Ebola mio amico. $STE EPA and CDC love Steramist. World Health Org needs to jump on this threat.
View on StockTwits ↗https://marketbeat.com/a/8656093/ $STE STERIS Q4 Earnings Call Highlights
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $6.4B | +7.2% | $11.15 | $11.12–$11.16 | 20.9× | 6 |
| 2028 | $6.8B | +6.3% | $12.14 | $12.10–$12.17 | 19.2× | 5 |
| 2029 | $7.2B | +6.5% | $13.20 | $13.06–$13.34 | 17.7× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $2.49 | $2.59 | +4.0% |
| 2026-05-11 | $2.85 | $2.83 | -0.7% |
| 2026-02-04 | $2.53 | $2.53 | +0.0% |
| 2025-11-05 | $2.35 | $2.47 | +5.1% |
| 2025-08-06 | $2.26 | $2.34 | +3.5% |
| 2025-05-14 | $2.60 | $2.74 | +5.4% |
| 2025-02-05 | $2.33 | $2.32 | -0.4% |
| 2024-11-06 | $2.12 | $2.14 | +0.9% |
| $26.1B |
| — |
| PHGKoninklijke Philips N.V. | $27.29 | -0.33% | $26.7B | — |
| PODDInsulet Corp. | $143.34 | -2.12% | $9.9B | — |
Source: Financial Modeling Prep · peers by sector/industry